Successfully launching a new drug for a complex disease like cardiorenal disease (CKD) requires a well-planned approach. This approach should focus on educating target HCPs for disease education.
Medical affairs teams play a crucial role in this process by leveraging their expertise in scientific communication and collaboration with key stakeholders. Download our case study to learn how one global pharma company created a targeted HCP education program in primary care and with top treaters by leveraging H1’s platform.
Download the case study.